Atlas Trials

Bleeding Time Study With AZD6482, Clopidogrel and ASA

Clinical trial NCT00853450 · COMPLETED

Trial details

NCT number
NCT00853450
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Antiplatelet Effect
Start date
2009-02-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.